Adil El Housseini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Adil El Housseini has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Imade Armadi
Cadi Ayyad University, Morocco
4 shared publications Moulay Abdelmonaim El Hidan
4 shared publicationsYoussef Ait Hamdan
4 shared publications- Anass Belbachir
Cadi Ayyad University, Marrakech, Morocco
3 shared publications El Hassan El Mouden
Laboratory of Water Science, Microbial Biotechnology, and Sustainability of Natural Resources, Faculty of Science Semlalia, Cadi Ayyad University, Marrakech, Morocco
3 shared publications- Fatima Ezzahra Elamrani
Cadi Ayyad University, Morocco
3 shared publications
Latest Publications
- Open Access
- 19 October 2026
- Published by Elsevier in Next Bioengineering
- Vol. 3
Biomaterials derived from bioresources as therapeutic tools against scorpion envenomation
- 19 October 2026
- Published by Elsevier in Next Bioengineering
- Vol. 3
Open AccessBiomaterials derived from bioresources as therapeutic tools against scorpion envenomation
- Open Access
- 15 September 2026
- Published by Elsevier in Next Materials
- Vol. 13
Extraction, characterization, and pharmacological investigations of chitosan from the scorpion Scorpio mogadorensis (Birula, 1910)
- 15 September 2026
- Published by Elsevier in Next Materials
- Vol. 13
Open AccessExtraction, characterization, and pharmacological investigations of chitosan from the scorpion Scorpio mogadorensis (Birula, 1910)
- 10 July 2026
- Published by IGI Global Scientific Publishing
- p. 301-340
Scorpion Venom and Biodegradable Biomaterials
Scorpion venom is known for its richness in bioactive molecules, particularly peptides, which confer a wide range of remarkable biological activities. Notably, it exhibits antimicrobial, antitumor, and immunomodulatory effects. However, its clinical translation remains limited due to its poor stability, dose-dependent toxicity, and potential immunogenicity. In this context, biodegradable biomaterials have emerged as promising platforms to overcome these limitations. They enable precise, targeted, and sustained delivery of scorpion venom peptides. This chapter highlights an innovative approach based on the integration of scorpion venom into biodegradable biopolymer matrices for applications in modern medicine. By leveraging the unique properties of biodegradable biomaterials, this work outlines a roadmap for the development of next-generation clinical applications.
- 10 July 2026
- Published by IGI Global Scientific Publishing
- p. 301-340
Scorpion Venom and Biodegradable Biomaterials
Scorpion venom is known for its richness in bioactive molecules, particularly peptides, which confer a wide range of remarkable biological activities. Notably, it exhibits antimicrobial, antitumor, and immunomodulatory effects. However, its clinical translation remains limited due to its poor stability, dose-dependent toxicity, and potential immunogenicity. In this context, biodegradable biomaterials have emerged as promising platforms to overcome these limitations. They enable precise, targeted, and sustained delivery of scorpion venom peptides. This chapter highlights an innovative approach based on the integration of scorpion venom into biodegradable biopolymer matrices for applications in modern medicine. By leveraging the unique properties of biodegradable biomaterials, this work outlines a roadmap for the development of next-generation clinical applications.
Kinetics of brain oxidative stress in mice after envenomation by Hottentotta gentili (Pallary, 1924)
- 7 November 2025
- Published by IGI Global Scientific Publishing
- p. 133-166
Secondary Metabolites
Alzheimer's, Parkinson's, and various neurodegenerative diseases are generally characterized by neuronal loss, which directly induces cognitive and motor dysfunctions. Secondary metabolites, as natural products of aromatic and medicinal plants and other origins, could present a promising alternative source to combat neurodegenerative diseases. With their important phytochemical composition, especially in alkaloids, terpenes, flavonoids, and polyphenols, these secondary metabolites pave the way for the development of new therapies. Their neuroprotective properties and their antioxidant and anti-inflammatory activities constitute a solid basis for their use in the fight against neurodegenerative diseases. This chapter aims to explore the therapeutic effects of secondary metabolites in the fight against neurodegenerative diseases while discussing the responsible mechanisms, challenges, perspectives, as well as the limits of this application.
- 7 November 2025
- Published by IGI Global Scientific Publishing
- p. 133-166
Secondary Metabolites
Alzheimer's, Parkinson's, and various neurodegenerative diseases are generally characterized by neuronal loss, which directly induces cognitive and motor dysfunctions. Secondary metabolites, as natural products of aromatic and medicinal plants and other origins, could present a promising alternative source to combat neurodegenerative diseases. With their important phytochemical composition, especially in alkaloids, terpenes, flavonoids, and polyphenols, these secondary metabolites pave the way for the development of new therapies. Their neuroprotective properties and their antioxidant and anti-inflammatory activities constitute a solid basis for their use in the fight against neurodegenerative diseases. This chapter aims to explore the therapeutic effects of secondary metabolites in the fight against neurodegenerative diseases while discussing the responsible mechanisms, challenges, perspectives, as well as the limits of this application.
- 26 September 2025
- Published by IGI Global Scientific Publishing
- p. 205-232
Therapeutic Implications of Chitosan and Its Derivatives
Chitosan and its derivatives have garnered increasing interest in oncology due to their unique properties, such as biocompatibility, bioactivity and their ability to interact with molecules. These characteristics make them promising candidates for the development of novel anticancer therapies. Chitosan can be employed as drug delivery systems, enhancing the availability and targeted release of therapeutic agents into cancer cells. Additionally, they have demonstrated the ability to inhibit cell proliferation, induce apoptosis, and modulate immune responses, positioning them as multifunctional tools in the fight against cancer. Recent research has focused on the development of chitosan-based nanoparticles for targeted drug delivery in chemotherapy, reducing side effects on healthy cells. Furthermore, Chitosan systems have been used to deliver siRNA and other therapeutic molecules, inhibiting tumor growth at the genetic level. These advancements highlight chitosan's potential in developing more effective and less toxic cancer treatments.
- 26 September 2025
- Published by IGI Global Scientific Publishing
- p. 205-232
Therapeutic Implications of Chitosan and Its Derivatives
Chitosan and its derivatives have garnered increasing interest in oncology due to their unique properties, such as biocompatibility, bioactivity and their ability to interact with molecules. These characteristics make them promising candidates for the development of novel anticancer therapies. Chitosan can be employed as drug delivery systems, enhancing the availability and targeted release of therapeutic agents into cancer cells. Additionally, they have demonstrated the ability to inhibit cell proliferation, induce apoptosis, and modulate immune responses, positioning them as multifunctional tools in the fight against cancer. Recent research has focused on the development of chitosan-based nanoparticles for targeted drug delivery in chemotherapy, reducing side effects on healthy cells. Furthermore, Chitosan systems have been used to deliver siRNA and other therapeutic molecules, inhibiting tumor growth at the genetic level. These advancements highlight chitosan's potential in developing more effective and less toxic cancer treatments.
- 26 September 2025
- Published by IGI Global Scientific Publishing
- p. 257-294
Chitosan Polysaccharides for Osteoporosis Therapy in Postmenopausal Women
Osteoporosis is a common degenerative disease in postmenopausal women, characterized by a loss of bone density and skeletal fragility, increasing fracture risk. This chapter examines the use of chitosan, a natural biopolymer derived from chitin, as a therapeutic agent in osteoporosis treatment. Chitosan's unique properties, such as biocompatibility, biodegradability, and the ability to form three-dimensional structures, make it a promising candidate for bone therapies. The chapter also analyzes chemical and functional modifications to chitosan that enhance its bioactive effects and drug delivery capabilities, offering promising perspectives for non-hormonal osteoporosis treatments.
- 26 September 2025
- Published by IGI Global Scientific Publishing
- p. 257-294
Chitosan Polysaccharides for Osteoporosis Therapy in Postmenopausal Women
Osteoporosis is a common degenerative disease in postmenopausal women, characterized by a loss of bone density and skeletal fragility, increasing fracture risk. This chapter examines the use of chitosan, a natural biopolymer derived from chitin, as a therapeutic agent in osteoporosis treatment. Chitosan's unique properties, such as biocompatibility, biodegradability, and the ability to form three-dimensional structures, make it a promising candidate for bone therapies. The chapter also analyzes chemical and functional modifications to chitosan that enhance its bioactive effects and drug delivery capabilities, offering promising perspectives for non-hormonal osteoporosis treatments.
- 26 September 2025
- Published by IGI Global Scientific Publishing
- p. 1-30
Biomedical Polymers
Biomedical polymers have played a transformative role in modern medicine, driving innovation in drug delivery, tissue engineering and medical devices. These materials are classified as natural or synthetic and possess unique properties such as biocompatibility, biodegradability and mechanical versatility. Natural polymers support cellular functions and tissue regeneration, while synthetic polymers allow precise control of degradation rates and mechanical properties. Polymers have facilitated the controlled delivery of drugs through polymer-drug conjugates and stimulant systems, enabling targeted and sustained release. However, challenges such as toxicity, immune responses and regulatory hurdles remain. By exploring their applications, challenges and future prospects, this chapter has shed light on the essential role of biomedical polymers in advancing personalized medicine, regenerative therapies and smart medical devices.
- 26 September 2025
- Published by IGI Global Scientific Publishing
- p. 1-30
Biomedical Polymers
Biomedical polymers have played a transformative role in modern medicine, driving innovation in drug delivery, tissue engineering and medical devices. These materials are classified as natural or synthetic and possess unique properties such as biocompatibility, biodegradability and mechanical versatility. Natural polymers support cellular functions and tissue regeneration, while synthetic polymers allow precise control of degradation rates and mechanical properties. Polymers have facilitated the controlled delivery of drugs through polymer-drug conjugates and stimulant systems, enabling targeted and sustained release. However, challenges such as toxicity, immune responses and regulatory hurdles remain. By exploring their applications, challenges and future prospects, this chapter has shed light on the essential role of biomedical polymers in advancing personalized medicine, regenerative therapies and smart medical devices.
- 26 September 2025
- Published by IGI Global Scientific Publishing
- p. 233-256
Radioprotective Effects of Chitosan Polysaccharides and Biomedical Applications
Ionizing radiation (IR) plays a central role in the biomedical field, both for diagnosis and for the treatment of pathologies such as cancer. However, exposure to IR can cause significant cellular damage, affecting both tumor cells and neighbouring healthy tissue. In this context, the use of effective radioprotective agents is a necessity. Chitosan (CS), a natural biopolymer derived from chitin, stands out for its antioxidant, anti-inflammatory and reparative properties, as well as its biocompatibility and biodegradability. These characteristics make it a promising candidate for radiation protection. This chapter examines the radioprotective mechanisms of chitosan, in particular its ability to trap reactive oxygen species and enhance the activity of antioxidant enzymes. It also highlights its many biomedical applications, particularly in tissue engineering and controlled drug release. Finally, the limits to its clinical use and recent advances aimed at improving its physico-chemical properties are discussed, paving the way for new therapeutic strategies in radiation protection.
- 26 September 2025
- Published by IGI Global Scientific Publishing
- p. 233-256
Radioprotective Effects of Chitosan Polysaccharides and Biomedical Applications
Ionizing radiation (IR) plays a central role in the biomedical field, both for diagnosis and for the treatment of pathologies such as cancer. However, exposure to IR can cause significant cellular damage, affecting both tumor cells and neighbouring healthy tissue. In this context, the use of effective radioprotective agents is a necessity. Chitosan (CS), a natural biopolymer derived from chitin, stands out for its antioxidant, anti-inflammatory and reparative properties, as well as its biocompatibility and biodegradability. These characteristics make it a promising candidate for radiation protection. This chapter examines the radioprotective mechanisms of chitosan, in particular its ability to trap reactive oxygen species and enhance the activity of antioxidant enzymes. It also highlights its many biomedical applications, particularly in tissue engineering and controlled drug release. Finally, the limits to its clinical use and recent advances aimed at improving its physico-chemical properties are discussed, paving the way for new therapeutic strategies in radiation protection.
- 25 April 2025
- Published by IGI Global Scientific Publishing
- p. 51-90
Overview of Biomaterials Classification, Properties, and Biomedical Applications
Biomaterials have attracted growing interest in the biomedical field thanks to their unique ability to interact with biological systems and make a significant contribution to advances in medicine, tissue engineering and sustainable technologies. Their importance lies in their dual potential: improving patients' quality of life while reducing their impact on the environment. This chapter first presents a detailed classification of biomaterials, distinguishing between natural, synthetic and hybrid categories. Next, the key properties of biomaterials are explored, showing their role in biocompatibility, durability and clinical performance. These fundamental characteristics directly influence the choice of biomaterials for a variety of applications. In addition, this chapter highlights the diversity of current biomaterial applications, while discussing the persistent challenges and limitations encountered in their design and use. Finally, future prospects are discussed, including the emergence of personalized biomaterials, which could revolutionize biomedical technologies.
- 25 April 2025
- Published by IGI Global Scientific Publishing
- p. 51-90
Overview of Biomaterials Classification, Properties, and Biomedical Applications
Biomaterials have attracted growing interest in the biomedical field thanks to their unique ability to interact with biological systems and make a significant contribution to advances in medicine, tissue engineering and sustainable technologies. Their importance lies in their dual potential: improving patients' quality of life while reducing their impact on the environment. This chapter first presents a detailed classification of biomaterials, distinguishing between natural, synthetic and hybrid categories. Next, the key properties of biomaterials are explored, showing their role in biocompatibility, durability and clinical performance. These fundamental characteristics directly influence the choice of biomaterials for a variety of applications. In addition, this chapter highlights the diversity of current biomaterial applications, while discussing the persistent challenges and limitations encountered in their design and use. Finally, future prospects are discussed, including the emergence of personalized biomaterials, which could revolutionize biomedical technologies.